Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 41 EP49 | DOI: 10.1530/endoabs.41.EP49

1Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; 2Endocrinology Clinic, Cluj-Napoca, Romania; 3Carol Davila University of Medicine and Pharmacy & C.I. Parhon National Institute of Endocrinology, Bucuresti, Romania; 4Department of Radiotherapy, Prof. Dr. Ion Chiricuta Oncology Institute Cluj-Napoca, Cluj-Napoca, Romania.


Introduction: Cushing’s disease (CD) is caused by high adrenocorticotropic hormone (ACTH), usually by a pituitary microadenoma.

Material and method: This is a case report investigated in several Romanian centers by performing: morning plasma cortisol, circadian rhythm of plasma cortisol, plasma ACTH, dexamethasone (DXM) suppression tests.

Case data: A 57-year female, known with hypertension and osteopenia, was admitted for high blood pressure, fatigue, anxiety, sweating and hirsutism. Clinical examination revealed: moon face, plethora, hirsutism (on upper lip, lower jaw, sideburn, lower abdomen and thigh; Ferriman-Gallwey score of 18, centripetal obesity; buffalo hump, enlarged supra-clavicle fat pads and cervical. Endocrine evaluation indicated normal thyroid function with positive anti-thyreoglobulin antibodies (283.3 UI/ml, normal <50 UI/ml), high levels of morning plasma cortisol (249 ng/ml, normal 70–225 ng/ml) with loss of circadian rhythm, ACTH level within the upper reference range (41.1 pg/ml, normal <46 pg/ml) and a very high testosterone level (6.1 ng/ml, normal 0.2–0.75 ng/ml). Biochemical parameters indicated hypertriglyceridemia, low potassium and neutrophilia. Non-suppression at DXM 1 mg overnight test and 50% suppression at high dose of DXM leaded to a diagnosis of CD. Imagery did not identify any tumor. No ovarian, neither adrenal tumor was found in correlation to high testosterone levels so CD was considered the only cause.

Therefore the patient was treated with steroid synthesis inhibitor-Ketoconazole (800 mg/day), with clinical improvement: decrease of hirsutism and normalization of testosterone level to 0.2 ng/ml within months. Follow-up and a definitive therapy is needed.

Conclusions: Severe hyperandrogenism as seen here in CD is rare, most probably is correlated with adrenal androgen production and thyroid autoimmunity is incidental; therapeutically control of CD represents a clue of the etiological diagnosis of hyperandrogenemia.

Article tools

My recent searches

No recent searches.